跳至主要内容
临床试验/NCT02044575
NCT02044575已完成不适用

Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study

Claudia Spies1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Claudia Spies
入组人数
20
试验地点
1
主要终点
Assessment of circadian regulation

研究概览

简要总结

Despite large efforts trying to improve diagnostic and therapy of sepsis have been made over the last decade (e.g. initiation of the Surviving Sepsis Campaign, defining evidence based sepsis therapy bundles) the mortality of septic shock remains high and causes high socioeconomical burden of disease.

The purpose of this pilot study is to evaluate the design and conduct of a projected full scale clinical trial.

详细描述

A functional clock is required for induction of several proinflammatory genes, not shown in septic patient settings, yet.

Clock genes are involved in modulating the activity of several transcription factors that are important regulators of immune functions (e.g. HIF1-α, STAT1, STAT3, and NF-κB) (Bellet MM et al., 2013).

Furthermore, polymorphisms such as rs7221412, a common polymorphism near period homolog 1 (PER1), was associated with the timing of activity rhythms and also showed a suggestive time-dependent relationship with both cerebral cortex and monocytes PER1 expression and an association with time of death (Lim ASP et al., 2012).

This explorative project is a pilot study. First data are generated for the assessment of the circadian system in patients with septic shock.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients with age 18 years and above,
  • Patient at intensive care units (8i, 9i and 1i at Charité - University Medicine Berlin , Campus Virchow- Klinikum),
  • Septic shock (ACCP/SCCM (American College of Chest Physicians/Society of Critical Care Medicine) consensus definitions) AND Norepinephrine dosage of >0.3 μg/kg/min for at least 2 hours

排除标准

  • Pregnant or lactating female patient,
  • Participation in another interventional study (30 days before study inclusion and during study participation),
  • Acute leucemia,
  • Severe leukocytosis (>50,000/nl),
  • Severe thrombocytopenia (<5,000/nl),
  • Autoimmune disease with systemic medication of ≥10 mg prednisolone equivalent or previous transplantation,
  • Patients receiving interferon therapy (last 14 days),
  • Patients with known hypersensitivity GM-CSF or known antibodies against GM-CSF, yeast-derived products or any component of the study medication,
  • Ongoing (concomitant) chemotherapy or radiotherapy for malignancy,
  • Acute pulmonary embolism or acute myocardial infarction within last 72 hours,
  • Cardiopulmonary resuscitation within last 7 days,
  • Moribund patient (life expectancy <72 hrs.),
  • Presence of a do-not-resuscitate or do-not-intubate order,
  • Known human immunodeficiency virus (HIV) infection or chronic viral hepatitis
  • Lacking willingness to save and hand out data within the study
  • Accommodation in an institution due to an official or judicial order
  • The informed consent of the patient or the subject's legally acceptable representative can´t be obtained in time
  • Patient has a power of attorney or patient's provision, where he/she refuses participation in any clinical trial

结局指标

主要结局

Assessment of circadian regulation

时间窗: These parameters are measured during intensive care unit stay, for a maximum of 3 days

Circadian regulation by expression of clock genes

次要结局

  • Sequential Organ Failure Assessment (SOFA)(They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.)
  • Time on mechanical ventilation(They are followed up until the end of intensive care unit stay - or, for a maximum of 28 days)
  • Hospital length of stay(Participants will be followed for the duration of intensive care stay, an expected average of 5 weeks)
  • Simplified Acute Physiology Score (SOFA II)(They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.)
  • Therapeutic Intervention Scoring System (TISS-28)(They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.)
  • Light levels (lux)(Light levels are measured until the end of intensive care unit stay - or, for a maximum of 28 days)
  • Cortisol(This parameter is measured in ng/ml during intensive care unit stay, for a maximum of 3 days)
  • Intensive care unit length of stay(Participants will be followed for the duration of intensive care stay, an expected average of 4 weeks)
  • Melatonin(This parameter is measured in pg/ml during intensive care unit stay, for a maximum of 3 days)
  • Cognitive function(Up to 3 and 6 months)
  • Mortality(6 months after intensive care unit discharge)
  • Light frequencies(Light frequencies are measured until the end of intensive care unit stay - or, for a maximum of 28 days)
  • Quality of life(Up to 3 and 6 months)
  • Multiplex-Genexpression analysis(These parameters are measured during intensive care unit stay, for a maximum of 3 days)

研究者

发起方
Claudia Spies
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Claudia Spies

Department of Anesthesiology and Intensive Care Medicine, CVK/CCM, Charité - University Medicine Berlin

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验